Wall Street brokerages expect that Nu Skin Enterprises, Inc. (NYSE:NUS) will report $561.32 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Nu Skin Enterprises’ earnings. The lowest sales estimate is $555.54 million and the highest is $567.09 million. Nu Skin Enterprises posted sales of $499.10 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 12.5%. The business is expected to announce its next earnings report on Wednesday, May 2nd.
On average, analysts expect that Nu Skin Enterprises will report full year sales of $561.32 million for the current year, with estimates ranging from $2.46 billion to $2.47 billion. For the next financial year, analysts expect that the business will report sales of $2.53 billion per share. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Nu Skin Enterprises.
Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Thursday, February 15th. The company reported $1.20 EPS for the quarter, topping the Zacks’ consensus estimate of $1.19 by $0.01. The firm had revenue of $666.20 million during the quarter, compared to analyst estimates of $667.39 million. Nu Skin Enterprises had a return on equity of 25.23% and a net margin of 5.68%. The company’s revenue was up 25.4% on a year-over-year basis. During the same period last year, the company earned $0.79 earnings per share.
Several research firms have recently issued reports on NUS. Deutsche Bank boosted their target price on Nu Skin Enterprises from $75.00 to $77.00 and gave the stock a “buy” rating in a research report on Friday, February 16th. Pivotal Research restated a “buy” rating and set a $90.00 target price on shares of Nu Skin Enterprises in a research report on Friday, February 16th. ValuEngine upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Citigroup restated a “buy” rating and set a $81.00 target price (up from $70.00) on shares of Nu Skin Enterprises in a research report on Tuesday, January 23rd. Finally, Zacks Investment Research upgraded Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $78.00 target price for the company in a research report on Saturday, December 30th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the company. Nu Skin Enterprises has a consensus rating of “Hold” and an average target price of $71.29.
In other news, CFO Mark H. Lawrence sold 724 shares of Nu Skin Enterprises stock in a transaction dated Friday, March 9th. The stock was sold at an average price of $72.86, for a total transaction of $52,750.64. Following the transaction, the chief financial officer now owns 11,473 shares in the company, valued at approximately $835,922.78. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, General Counsel D Matthew Dorny sold 3,000 shares of Nu Skin Enterprises stock in a transaction dated Monday, March 5th. The shares were sold at an average price of $72.69, for a total value of $218,070.00. Following the transaction, the general counsel now owns 44,399 shares in the company, valued at approximately $3,227,363.31. The disclosure for this sale can be found here. Insiders have sold a total of 214,702 shares of company stock valued at $14,863,554 over the last 90 days. Corporate insiders own 5.20% of the company’s stock.
Large investors have recently added to or reduced their stakes in the company. Trexquant Investment LP bought a new position in shares of Nu Skin Enterprises during the 3rd quarter valued at about $455,000. Convergence Investment Partners LLC lifted its holdings in shares of Nu Skin Enterprises by 14.2% during the 3rd quarter. Convergence Investment Partners LLC now owns 65,602 shares of the company’s stock valued at $4,033,000 after purchasing an additional 8,134 shares in the last quarter. Jennison Associates LLC bought a new position in shares of Nu Skin Enterprises during the 4th quarter valued at about $1,745,000. APG Asset Management N.V. lifted its holdings in shares of Nu Skin Enterprises by 159.2% during the 4th quarter. APG Asset Management N.V. now owns 402,500 shares of the company’s stock valued at $22,870,000 after purchasing an additional 247,200 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Nu Skin Enterprises by 5.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,416,305 shares of the company’s stock valued at $87,443,000 after purchasing an additional 66,986 shares in the last quarter. Institutional investors and hedge funds own 76.62% of the company’s stock.
Shares of Nu Skin Enterprises (NYSE:NUS) opened at $74.25 on Friday. The company has a quick ratio of 1.17, a current ratio of 1.74 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $3,832.29, a PE ratio of 22.42, a P/E/G ratio of 2.02 and a beta of 1.43. Nu Skin Enterprises has a 12-month low of $52.19 and a 12-month high of $75.00.
The business also recently announced a quarterly dividend, which was paid on Wednesday, March 14th. Stockholders of record on Monday, February 26th were given a dividend of $0.365 per share. This is a positive change from Nu Skin Enterprises’s previous quarterly dividend of $0.36. This represents a $1.46 annualized dividend and a dividend yield of 1.97%. The ex-dividend date of this dividend was Friday, February 23rd. Nu Skin Enterprises’s payout ratio is presently 61.60%.
ILLEGAL ACTIVITY NOTICE: This report was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2018/04/08/brokerages-anticipate-nu-skin-enterprises-inc-nus-will-post-quarterly-sales-of-561-32-million.html.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.